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Abstract
BACKGROUND: This project took place at a community-based rural hospital in eastern
Kentucky. During completion of a needs assessment, adoption of an evidence-based nursing
practice model and improvement of clinical outcomes of the community’s heart failure patient
population were revealed as opportunities.
PURPOSE: The purpose of this project was to introduce the organization’s key stakeholders to
the Johns Hopkins Nursing Evidence-Based Practice Model (JHNEBP), encourage
implementation of an evidence-based practice (EBP) committee, and to use heart failure as an
exemplar to facilitate discussions and stakeholder education.
METHODS: The goal of this project was to develop a supportive EBP culture through adoption
of the JHNEBP model. Methods included developing and launching a virtual nursing EBP
education module, developing an EBP committee, and utilizing the JHNEBP model and steps to
implement heart failure EBP’s at the project site. The University of Iowa Hospitals & Clinics
Nursing EBP Survey, 2005 edition, was administered pre and post EBP module education to
assess nurses’ perceptions of EBP.
RESULTS: Although post-intervention group scores (M=98.4, SD=14.1) improved from preintervention group scores (M=94.2, SD=13.5), Mann-Whitney U revealed no statistical
significance in pre and post score comparisons for survey subscales (organizational culture
(p=.156), unit culture (p=.165), nurses knowledge and skills (p=.301), time (p=.131), attitude
(p=.595)] or total score (p=.184).
CONCLUSION: Driving EBP culture changes may take up to three to five years (Dang &
Dearholt, 2017). This project was limited in both time and sample size (n=53), although
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statistical significance could not be determined in the pre-intervention and post-intervention
groups, continuation on the path of creating a supportive EBP culture is key in driving EBP care.
Keywords: evidence-based best practice model, Johns Hopkins nursing evidence-based
best practice model, heart failure, rural healthcare
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Introduction of an Evidenced-Based Practice Model to Improve Heart Failure at a Rural
Community Hospital
Introduction
Healthcare leaders must ensure the delivery of highly reliable, safe, and effective care
based on the latest evidence. In 1992, Pettigrew et al. noted that healthcare leaders must provide
an inspiring and supportive organizational environment if evidence-based practice (EBP)
changes are to be successful. Today, the need to successfully change practice in a quick and
efficient way has never been more evident. EBP is fostered by a supportive environment that
promotes lifelong learning and adaptation to the evidence (Dang, Dearholt, 2017). Developing a
supportive EBP environment can be assisted through the adoption of a nursing EBP model and
by establishing an EBP committee.
Background
This project took place in a community-based rural hospital in eastern Kentucky. During
a needs assessment that included key stakeholder interviews, improvement of heart failure
clinical outcomes was revealed as an opportunity for the organization and the community. In
order to successfully translate the latest heart failure evidence into practice adoption of an EBP
model is needed, this was also revealed as an opportunity for the organization. Heart failure is a
serious disease that affects nearly 6.5 million adults in the United States and is a leading cause of
death. Heart failure is a contributing cause in one out of every eight deaths (CDC, 2020). Not
only is heart failure a serious disease but it is also increasing incidence at alarming rates. From
2012 to 2030 the incidence of heart failure is expected to increase forty-six percent to more than
8 million adults in United States (Benjamin et al., 2017). Associated costs are expected to
increase by 127% to 69.7 billion dollars (Benjamin et al., 2017). Heart failure readmission and
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mortality rates are other key indicators to consider when evaluating the health of this population.
Kentucky ranks among the highest in heart failure mortality in the US, ranging from 238-706
deaths per 100,000 age-adjusted averages (CDC, 2018). The national heart failure readmission
rate is reported at 21.6%, from July 2015 to June 2018 (Hospital Compare, 2020). Since
inception of the Hospital Readmission Reduction Program (HRRP) hospitals have incurred over
2.5 billion dollars in readmission penalties (AHA, 2020). Adoption of a nursing EBP model can
assist in applying best practices to this heart failure patient population ultimately improving
clinical outcomes.
Problem Statement
The need to improve heart failure care across the United States and even more so in the
state of Kentucky is evident. The project site was not utilizing a nursing EBP model or EBP
committee to guide them in application of the latest evidence in the clinical setting, in this case
for the heart failure patient population.
Needs Assessment
This project took place at a ninety-licensed bed rural community hospital, located in
Eastern Kentucky. A multi-pronged needs assessment was completed including review of heart
failure healthcare outcomes data, key stakeholder interviews, and retrospective heart failure chart
audits.
Heart Failure Healthcare Outcomes Data
The hospitals heart failure readmission rate range was reported as 21.6%-22.3% from
July 2015 to June 2018, slightly above the national average of 21.6% (Hospital Compare, 2020).
The heart failure death rate per 100,000, age thirty-five and older, both genders and all race and
ethnicities from 2016 to 2018 for the nation was 174.7. Kentucky’s heart failure death rate was
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higher than the national rate at 240.3, and the project site, located in Lawrence County Kentucky,
was more than twice the national rate at 355.9 (CDC, 2020) (Appendix A).
Key Stakeholder Interviews
Key hospital stakeholders were interviewed including the Chief Nursing Officer (CNO),
Inpatient and Intensive Care Unit Nurse Manager, Cardiology Nurse Practitioner, Emergency
Department Manager, and subject matter experts including educators. Interviews revealed
implementation of EBP to be a challenge citing limited leadership positions and other resources
dedicated to this work as a primary concern. At the time of the interviews there was no structure
for translating the latest evidence into practice through an EBP nursing model or other
mechanism. Key stakeholders state the hospital policy committee attempts to review the latest
evidence when implementing or revising a policy. This committee does not review evidence
outside of standard policy review and has not reviewed EBP guidelines in general. Overall the
adoption of a nursing EBP model was determined to be a need. Key stakeholders were also
questioned to determine other EBP foundational elements including EBP education, inclusion of
EBP in nursing philosophy or nursing strategic plans, none of which were confirmed practices.
Stakeholders noted that inpatient programs specific to improving heart failure healthcare
outcomes had not been implemented. Although a fully developed program using an EBP model
had not been instituted, some singular initiatives had been implemented including development
of a heart failure patient education booklet and assuring follow-up appointments were made prior
to inpatient discharge. Consistency with adherence to these singular initiatives was determined to
be an issue through both the interview process and through retrospective chart audits.
The American College of Cardiology Foundation (ACCF) and American Heart
Association’s (AHA) EBP heart failure guidelines (ACCF & AHA, 2017) (Appendix B) were
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discussed during interviews with key stakeholders to determine overall impression of facility
alignment with the heart failure guidelines. Through these interviews, opportunity was identified
to develop evidence-based standardized heart failure order sets from clinical guidelines
supported by the ACCF & AHA. The use of evidence-based order sets has been shown to
decrease medical errors, decrease length of stay, and decrease mortality (Wells & Loshak, 2019).
However, key stakeholder interviews revealed that provider adoption of other standardized order
sets has been a challenge.
The ACCF & AHA heart failure guidelines state a follow-up visit within seven to
fourteen days should occur and/or a telephone follow-up within three days of hospital discharge
(ACCF & AHA 2017). Through interviews, it was revealed that key stakeholders felt that
discharge follow-up appointments occur most of the time however there is not currently a
process in place for follow-up telephone phone calls. Additionally, the facility does not have
other continuum of care programs such as a heart failure outpatient clinic, heart failure nurse
navigator, or other heart failure specialty programs. Patients are typically referred to their
cardiologist or primary care physician for follow-up post hospital discharge. The number of days
until the follow-up appointment vary and lack consistency although the importance of follow-up
was well understood.
The ACCF and AHA heart failure guidelines state patients with heart failure should
receive specific education to facilitate heart failure self-care (ACCF & AHA, 2017). Hospital
stakeholders shared they do not currently have an educational program for patients admitted with
heart failure. Interviews revealed that heart failure patient education booklets were created and
used, however, once all booklets were given out, additional booklets were not ordered. Through
stakeholder interviews it was reported that there is a plan in place to reorder more booklets and
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re-initiate distribution to patients admitted with heart failure. Furthermore, inpatient nurses lack
additional training on how to educate this patient population.
Retrospective Heart Failure Chart Audit Review
Hospital leadership completed a retrospective review of twenty-nine heart failure patient
charts admitted from November 2019 to May 2020. Of particular focus for this project, the
ACCF & AHA heart failure guidelines pertaining to follow-up care and education were
reviewed. As discussed previously, the guidelines state follow-up care should occur within seven
days of hospital discharge and/or telephone follow-up within three days of hospital discharge. Of
the twenty-nine charts reviewed thirty-four percent (n=10) had a scheduled follow-up
appointment within fourteen days or less from hospital discharge and twenty-four percent (n=7)
had an appointment within seven days or less. Telephone follow-up phone calls are not currently
a part of the workflow for heart failure patients; therefore zero percent (n=0) of the audits
reviewed had a telephone follow-up call.
As stated previously, ACCF & AHA guidelines state patients with heart failure should
receive specific education to facilitate heart failure self-care. Charts were audited to determine if
there was documentation of heart failure education, zero percent (n=0) answered yes to having
completed this education. Other education specific to heart failure risk factors, including
anticoagulation therapy education, diabetes education, and use of the AHA heart failure
interactive education workbook, were also audited for documentation to show completion. Less
than seven percent (n=2) of these were answered as having been completed.
The multi-pronged needs assessment revealed the need to create a supportive EBP
environment including adoption on an EBP model to assist in translating evidence into practice.
The findings of the retrospective chart audits, key stakeholder interviews, heart failure
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guidelines, and county and state statistics support the need to develop a heart failure EBP
program to improve the healthcare outcomes of this patient population. By establishing key
aspects of a supportive EBP environment including adoption of an EBP model, heart failure can
be used as an exemplar for translating evidence into practice and subsequently improving heart
failure healthcare outcomes for the patients and community of the project site.
Literature Review
When implementing performance improvement, nurses and their overall buy-in and
engagement of EBP is key in successfully translating evidence into practice. Therefore, literature
was reviewed pertaining to EBP as it relates to nurse engagement and translation of evidence into
practice. This project site is set at a rural community hospital therefore literature was reviewed
pertaining to rural application of an EBP nursing model. Lastly, using heart failure as the
exemplar for this project, literature was reviewed for EBP’s for heart failure care and its effect on
heart failure healthcare outcomes.
EBP: Nurses Engagement and Translation
Current literature was reviewed pertaining to nurse engagement and translation of
evidence into practice. Evidence suggests the need to increase nurses’ perceptions, knowledge,
and attitudes of EBP in order to effectively translate evidence into practice (Soleymanifar et al.,
2019; et. al, Sidani et al., 2016; Alqahtari et al., 2020). It is important to assess nurse confidence
levels of EBP and to provide continuing education with hands on performance improvement to
increase confidence of implementing EBP (Weaver et al., 2019). Additionally, the organizations
nurse leader’s knowledge and influence towards creating an EBP environment is key in building
a supportive EBP culture and translating evidence into practice (Bianchi et al., 2018). Creating a
supportive EBP culture is key to successful translation of current evidence into practice.
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American Nurses Credentialing Center (ANCC) designated Magnet or Pathway to Excellence ®
facilities were reported to have significantly fewer barriers to EBP when compared to nondesignated facilities. The literature suggests this may be due in part to existing framework that
supports embedding EBP into the culture of the organization (Wilson et al., 2015, Nguyen &
Wilson, 2016).
EBP: Rural Healthcare Application
Rural healthcare facilities are often challenged with lack of resources for developing an
EBP supportive environment (Munroe et al., 2006). Creative solutions should be sought to
overcome these barriers to drive EBP and ultimately improve overall quality of care in rural
healthcare. One study showed that a rural Magnet designated facility adopted the Johns Hopkins
Nursing Evidence-based Practice Model (JHNEBP) aiding them in creating a supportive EBP
environment (Weaver et al., 2019). Creating a supportive EBP environment in a rural healthcare
setting may be challenging but is as equally important as doing so in a large healthcare facility.
Implementing organizational changes to create an EBP supportive environment in rural
healthcare has been shown to improve nurse knowledge of EBP further supporting the translation
of evidence into practice (Munroe, 2006).
EBP: Application for Heart Failure
The AHA suggests that common barriers leading to heart failure readmission include
confusion with written discharge instructions, lack of understanding self-care instructions, and
not knowing who to contact if conditions worsen (AHA, 2019). In 2015, the AHA released a
scientific statement in which they describe patient education as a prominent factor that when
absent, may impede successful transitions of care in the heart failure patient population (Albert,
2015), (Appendix C). Heart failure education and follow-up care programs are components of

INTRO OF AN EBP MODEL TO IMPROVE HEART FAILURE 14
the ACCF & AHA heart failure EBP guidelines (ACCF & AHA, 2017). Current literature was
reviewed for additional supporting evidence for these two practices. Literature supports
implementation of patient education programs to improve heart failure self-care as evidenced by
increased SCHFI (self-care heart failure index) scores (Baptiste et al., 2016; Gonzago, 2018;
Liou et al., 2015; Rebello, 2017). Implementing an individualized patient heart failure
educational program should be considered to support the specific needs of the patient to obtain
best results. In one study, educational programs customized to baseline SCHFI scores were
shown to improve mean scores in self-care maintenance, self-care management, and overall
confidence levels (Gonzago, 2018).
Additionally, current literature supports the use of heart failure education programs in
combination with nurse-led follow up care programs to further support this patient population
through transitions of care (Baptiste et al., 2016; Rebello, 2017; Sezgin et al., 2017). Literature
demonstrated the implementation of a variety of timing and methods in the follow up care
programs that ranged from weekly follow up telephone calls (Rebello, 2017), follow up
telephone calls every two weeks for six months (Sezgin et al., 2017), to thirty-day follow up
telephone calls (Baptiste et al., 2016). Improvement in self-care was noted with each method.
The ACCF and AHA heart failure guidelines recommend a three-day follow-up telephone call or
a seven to fourteen-day follow-up visit with the provider (ACCF & AHA, 2017).
EBP: Application for Heart Failure and Healthcare Outcomes
Application of evidence-based practices on heart failure healthcare outcomes was
reviewed. Statistical significance of education and follow-up care programs on heart failure
readmission rates has been shown in research (Boyde et al., 2018; Clarkson et al., 2018; Son et
al., 2020). Other studies, although not determined to be statistically significant revealed
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decreases in heart failure readmission rates which may be considered clinically significant
(Baptiste et al., 2016; Liou et al., 2015; Rebello, 2017; Sezgin et al., 2017). In a meta-analysis of
eight randomized controlled trials Son et al., (2020) evaluated the effectiveness of nurse-led heart
failure education on heart failure healthcare outcomes, results revealed a significant reduction in
all-cause readmissions (risk ratio (RR)=0.75, 95% confidence interval (CI)=0.66-0.85), and heart
failure specific readmissions (RR=0.60, 95% CI=0.42-0.85).
Additionally, education programs focused on improving heart failure self-care may lead
to improved health-related quality of life (HRQL) and may also decrease clinical events such as
hospitalization (Asthana et al., 2017; Riegel et al., 2016; Rice et al., 2017). Follow-up care
programs have also been shown to decrease heart failure mortality when follow-up care was
received within seven days compared to thirty-days (hazard ratio [HR] 0.92; 95% confidence
interval [CI] 0.87–0.97), (Atzema et al., 2018). Type of setting for follow-up care may also have
an impact, Van Spall et al. (2018) found that follow-up programs that included nursing home
health visits (ranking P-score 0.6794; relative risk (RR) 0.78, 95% confidence intervals (CI)
0.62–0.98), and disease management clinics (ranking P-score 0.6368; RR 0.80, 95% CI 0.67–
0.97), most significantly reduced mortality.
Evidence Based Practice Model
The JHNEBP model was chosen for adoption for this project (Appendix D). The
JHNEBP uses a problem-solving approach to make timely clinical decisions. This model is
designed to meet the needs of the clinical nurse and nurse leaders using a process called PET
(practice question, evidence, and translation). Each category (practice question, evidence,
translation) is comprised of a series of actions for a total of nineteen action steps within the
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model (Appendix D & I). The goal of the model is to utilize the most recent evidence and
change clinical practice standards to assure best practice delivery.
Project Goal
The goal of this project was to develop a supportive EBP culture through adoption of the
JHNEBP model, doing so will position the organization to excel in healthcare outcomes for the
heart failure patient population as well as other targeted patient populations.
Project Design
This DNP project included introduction of the JHNEBP model (Appendix D) to the key
stakeholders through a virtual training course/module that was created by the primary
investigator, https://youtu.be/6rxs918Jl_M, (Appendix E). The module provided an overview of
EBP and the JHNEBP model, the benefits of creating an EBP supportive environment, and how
to utilize the JHNEBP model through defined action steps. The University of Iowa Hospitals and
Clinics Nursing EBP validated self-report survey, 2005 edition (Appendix F) was administered to
nurses pre and post EBP module education, a participant informed consent letter was sent along
with the electronic participation invitation (Appendix G). The EBP survey was administered
electronically via SurveyMonkey with permission from University of Iowa Hospitals and
Clinics.
The project encouraged implementation of an interprofessional EBP committee. An EBP
committee development plan was presented to the executive sponsor/CNO. The plan included an
EBP committee charter template, proposed EBP committee meeting frequency, and actions with
deliverables following JHNEBP steps and tools. Lastly, heart failure EBP guidelines and
literature were used as an exemplar to facilitate organization discussions and stakeholder
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education on the JHNEBP model. The JHNEBP model and steps were utilized to plan and
execute implementation of heart failure EBP’s at the project site.
Project Site and Population
The project took place at a ninety-bed rural community hospital located in Eastern
Kentucky in the small town of Louisa with a population of 2,375 (US Census Bureau, 2020). The
hospital has an average daily inpatient census of thirty patients, with patients seeking care from
surrounding rural counties and approximately ninety-five heart failure patients per year (Hospital
Compare, 2020). Project participants included the Chief Nursing Officer, administration,
cardiology, nursing, and other healthcare providers. Patients, families, and the community at
large are potential beneficiaries of the project.
Methods
The goal of this project was to develop a supportive EBP culture through adoption of the
JHNEBP model. Methods included developing and launching an EBP virtual module education
for hospitals nurses (Appendix E), developing an EBP committee implementation plan, and to
utilizing the JHNEBP model and steps to plan and execute implementation of heart failure EBP’s
at the project site. The University of Iowa Hospitals and Clinics Nursing EBP Survey, 2005
edition, was administered pre and post education to assess nurses’ perceptions of EBP (Appendix
F). The survey is composed of twenty-nine questions using a five-point Likert scale from
strongly disagree to strongly agree, subscales assess nurse perceptions of EBP in relation to
organizational culture, unit culture, nurse’s knowledge and skills, time and attitude. Additional
information obtained included nurse degree and education level. Survey participants were
emailed a link to the survey, participants included inpatient and emergency department bedside
Registered Nurses (RNs) and Licensed Practical Nurses (LPNs) as well as RN unit leaders.
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Reliability and validity have been established through a descriptive cross-sectional survey design
of 1,187 RNs. All factor loadings in the confirmatory factor analysis (CFA) model were positive
and significant (p<.001) (Crawford et al., 2020).
The JHNEBP model was reviewed as a guide for EBP change implementation (Appendix
D & I). The JHNEBP model and guidelines discuss how to create a supportive EBP culture
including adoption of an EBP model and imbedding EBP into values, norms, and the
organizational structure. Other key components involve building skills and knowledge of EBP
with the team, reviewing the organization’s strategic plan, and nursing philosophy to further
embed EBP into the culture (Dang, Dearholt, 2017). The JHNEBP PET steps were utilized to
walk project site leadership through EBP application for the heart failure patient population
Actions taken for each step during the project are listed in Table 1, and hospital stakeholders are
continuing to work through the remainder of the JHNEBP steps (Table 1).
Ethical Considerations/Protection of Human Subjects
Written consent was waived, participants were informed that completion of the survey
implies their willingness to participate in data collection (Appendix G). Surveys will not contain
any personal identifiable information. Survey data was transferred onto a Statistical Package for
the Social Sciences (SPSS) spreadsheet for analysis and data was secured electronically on a
password protected computer. The code to the computer was available to the DNP student only.
Internal Review Board (IRB) exempt review application was submitted and approved. This
project involves no collection of protected health information or patient interaction.
Results
Descriptive data analysis as well as a cross tabulation utilizing the non-parametric MannWhitney U test was completed using SPSS to determine if there was a significant difference
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between the un-matched pre-intervention and post-intervention groups. Although postintervention group scores (M=98.4, SD=14.1) improved from pre-intervention group scores
(M=94.2, SD=13.5) (Table 3); Mann-Whitney U analysis revealed no statistical significance in
pre and post score comparisons for survey subscales (organizational culture (p=.156), unit
culture (p=.165), nurses knowledge and skills (p=.301), time (p=.131), attitude (p=.595)] or total
score (p=.184) (Table 4).
Overall, there were more RN’s (n=46) than LPN’s (n=6) taking the survey, RN education
level was primarily associate or diploma degree (n=33), followed by bachelor prepared RN’s
(n=8) and masters prepared RN’s (n=4). Nurse degree and education level were also compared
against each subscale as well as the total score. LPN’s scored highest in total in the preintervention group (M=105.7, SD=16.1), compared to all other groups, however, were the only
group to decline total score in the post-intervention group (M=102.2, SD=12.4) (Table 3).
Bachelor prepared RN’s scored the highest in the pre-intervention group (M=99.2, SD=8.2) and
in the post-intervention group (M=109.1, SD=10.9) (Table 3).
Interpretation and Discussion
Although statistical significance could not be determined when comparing the pre and post
intervention groups all groups except the LPN group had an increase in their total score post
education. This suggests even a short-focused EBP education module has the potential to impact
nurses’ perceptions of EBP. The LPN group may have had a false sense of EBP knowledge prior
to the EBP education module, as there is often little to no time dedicated to EBP education on the
LPN curriculum however, more evidence is needed to validate this assumption. This explanation
may explain a decline in the LPN scores after the EBP education module. Sample size (n=53)
and short implementation time may be limitations of the study and subsequent results given that
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embedding EBP culture changes may take up to three to five years to take full effect (Dang &
Dearholt, 2017).
EBP Model Implementation
The JHNEBP model worked effectively for this project and was well received by the team for
the simplicity of application and ability to easily adapt to future projects. The stakeholders and
EBP committee members now have meeting templates and tools utilizing the JHNEBP steps to
help guide meeting discussions and project work for continuation of this project as well as future
projects to help maintain momentum and feasibility.
The executive sponsor/CNO is very excited and engaged about continuing to establish the
initiatives to create a supportive EBP culture into their organization to ensure future sustainment
of EBP (Dang & Dearholt, 2017). These initiatives include adoption of a nursing EBP model and
developing and EBP committee both of which have been completed. Other initiatives include
revising the nursing philosophy to include EBP, developing a strategic plan in which all levels of
the organization are committed to EBP, ensuring committed organizational leadership,
identifying and developing mentors and informal leaders for EBP, identifying and overcoming
barriers to EBP, leading EBP change and managing transition, and building capacity for EBP. It
is also important to develop EBP skills and knowledge through interprofessional collaboration
and to set expectations for EBP during onboarding, when defining role expectations, and through
education, competencies, and performance evaluations (Dang & Dearholt, 2017).
Barriers and Risks
Barriers and risks to ongoing success were discussed and primarily focused on the list of
initiatives for creating an EBP culture. Three primary concerns evolved from the list of initiatives
including dissemination of EBP across all disciplines, developing plans for continued education,
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and future project planning. Stakeholders discussed how to alleviate these perceived barriers and
developed mitigation steps for the concerns. The first mitigating factor the CNO discussed was
working with the executive team to build EBP into the upcoming years strategic plan and
subsequent team members annual goal setting and evaluation process in a meaningful way. This
will assure EBP is embedded into all levels and disciplines throughout the organization.
Secondly, development of a general EBP education module for all disciplines will be completed.
Lastly, the EBP committee will prepare an annual EBP project plan to be presented to the
executive team for buy-in and support. Communication of annual plans will be shared with all
team members prior to and throughout the year for increased engagement and participation.
Next Steps
This project was completed through the evidence portion of the JHNEBP model. The
executive sponsor and other key stakeholders are happy they are seeing positive results thus far.
Next steps include completion of the JHNEBP translation steps for heart failure evidence-based
best practices, adoption of remaining ACCF & AHA heart failure guidelines, and monitoring for
success using the plan, do, study, act (PDSA) method (ASQ, 2016).
JHNEBP translation step twelve includes determining the fit, feasibility, and
appropriateness of the recommendations, next steps may include EBP committee open discussion
to identify any risk and potential mitigation steps and gaining group consensus. Step thirteen
involves creating an action plan, next steps may be to utilize an established action plan template
to work through action milestones, timeline and assigned responsible person(s). Step fourteen is
to secure support and resources to implement the action plan, this may be accomplished through
the executive sponsor gaining support with her executive colleagues as well as discussion with
key stakeholders explaining the value and impact of the project. Step fifteen of translation is to
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implement the action plan, this will be accomplished through the assigned responsible person(s)
by the identified timeline. Step sixteen is to evaluate the outcomes, this will be done by
identifying metrics potential primary outcome metrics may include auditing for consistency of
heart failure education and follow-up appointments and potential secondary outcomes may
include heart failure healthcare outcomes such as readmission and mortality rate reductions. Step
seventeen is to report outcomes to stakeholders, next steps may include weekly or monthly share
of primary outcome audits as well as sharing secondary outcome metrics for heart failure
readmission and mortality rates monthly or quarterly. Step eighteen is to identify next steps,
recommendations may include reviewing what went well and continued areas of needed
improvement and determining next course of action for continued acceleration of core
objectives. Lastly, step nineteen is to disseminate project findings, once reaching this step
recommendations are to share successes and failures with all key stakeholders, tying back
success to the core purpose of positively improving healthcare outcomes of the heart failure
patient population.
Next steps for adoption of the remaining ACCF & AHA heart failure guidelines may
include further JHNEBP cycles to determine next phase of incorporating the remaining
recommendations. Key stakeholders have discussed methods for accelerating adoption of the
guidelines including development of a heart failure admission order set and to work across the
care continuum with key stakeholders to streamline tools, resources, and collaboration for best
patient outcomes. The executive sponsor/CNO has great engagement and momentum in
continuing this work and has already begun mapping out future projects with other key patient
populations including palliative care patient populations.
Cost-Benefit Analysis/Budget
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Costs were estimated based on hourly salary cost for time and participation on the EBP
committee. An average of two hours per month per committee member was utilized, annualized
to twenty-four hours per year. Average salaries were obtained from web searches for position and
area and averaged among the resources. The EBP committee plans to meet during regular
business hours therefore additional pay will not be required in most cases. The annualized cost
maximum, if all salaries were paid above regular pay, would be estimated at $8,112 (Appendix
H, table 1). The benefit of reduced readmissions far outweighs the cost of this program with an
overall readmission annualized penalty estimated at $153,286 (Appendix H, table 2).
Limitations
Project limitations include length of time of the project and the small sample size for
testing pre and post-intervention group changes, and single site rural community hospital setting.
This project was completed in less than four-months, EBP supportive environment/culture
changes require three to five years (Dang & Dearholt, 2017). Although some of the EBP
supportive environment initiatives were started, such as adoption of the JHNEBP model, it will
take time to deploy all initiatives and for them to truly embed into the culture (Appendix E). The
sample size (n=53) of the pre and post-intervention group changes was very low, larger studies in
multiple settings would be beneficial in establishing reliability and validity for application in
other types and sized organizations.
Conclusion
In conclusion, this DNP project’s aim was to assist a rural community hospital in
implementing an EBP model and EBP committee to continuously evaluate evidence and translate
into clinical practice, ultimately improving healthcare outcomes of the community. By adopting
the JHNEBP model, an easy to use framework can be established to guide hospital leadership
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and staff towards sustained application of the latest evidence. Project limitations include both
timespan for implementation and sample size. Although statistical significance could not be
determined, all participant pre and post-intervention means scores improved. It is important to
continue on the path of creating an EBP culture in order to drive EBP care and ultimately
improve healthcare outcomes of patients.
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Table 1
JHNEBP PET Steps and Project Application
JHNEBP Step: Practice

Action Completed

Step 1. Recruit interprofessional team

EBP committee plan was developed and shared and promptly
implemented by the CNO.

Step 2. Define the problem

The new EBP committee reviewed the current state of the heart
failure population and developed a problem statement noting the
need to improve patient education and follow-up care processes.

Step 3. Develop and refine the EBP
question

The EBP committee developed the EBP question “Can we
improve heart failure patient outcomes by strengthening our
patient education and follow-up care programs based on EBP
guidelines?”

Step 4. Identify Stakeholders

Project key stakeholders were identified by the executive
sponsor/CNO.

Step 5. Determine responsibility for
project leadership

The project leader was identified as the CNO, a charter template
was utilized to form the committee structure which included
members, roles and responsibilities, committee purpose, measures
of success and key milestones.

Step 6. Schedule team meetings

Team meetings began with a kickoff meeting with the new EBP
committee, subsequent meeting frequency was determined.

JHNEBP Steps: Evidence
Step 7. Conduct internal and external
search for evidence

Evidence previously collected for heart failure care and treatment
was shared with the EBP committee as a starting point.

Step 8. Appraise the level and quality
of each piece of evidence

Previous appraisal was shared as well as appraisal tools from the
JHNEBP model and guidelines (Dang, Dearholt, 2017).
Additionally, the ACCF & AHA heart failure guidelines were
assessed by utilizing the AGREE (Appraisal of Guidelines for
Research and Evaluation) II instrument. The EBP committee
strongly agreed to the adoption of the guidelines following this
exercise. The AGREE II instrument was developed to address
variability and quality in EBP guidelines (AGREE Next Steps
Consortium, 2017).

Step 9. Summarize the individual
evidence

Summary of the evidence was completed and discussed.

Step 10. Synthesize overall strength
and quality of evidence

Evidence was evaluated for strength and quality of evidence using
the American Association of Critical Care Nurses (AACNs’s)
level of evidence rating system (AACN, 2021).
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Step 11. Develop recommendations
for change based on evidence
synthesis

During this phase the committee determined EBP changes to
adopt, beginning with heart failure patient education and followup care programs.

JHNEBP Steps: Translation

At the conclusion of the project the EBP committee was beginning
work on the translation steps.

Step 12. Determine fit, feasibility, and
appropriateness of
recommendation(s) for translation
path

Next steps may include EBP committee open discussion to
identify any risk and potential mitigation steps and gaining group
consensus.

Step 13. Create action plan

Next steps may be to utilize an established action plan template to
work through action milestones, timeline and assigned responsible
person(s).

Step 14. Secure support and resources
to implement action plan

Next steps may include the executive sponsor gaining support with
her executive colleagues as well as discussion with key
stakeholders explaining the value and impact of the project.

Step 15. Implement action plan

Next steps would include accomplishment of action through the
assigned responsible person(s) by identified timeline.

Step 16. Evaluate outcomes

Next steps for evaluating outcomes would be identifying what will
be measured and how often. Primary outcomes may include
auditing for consistency of completion of heart failure education
and follow-up appointments, secondary outcomes may include
measuring heart failure healthcare outcomes such as readmission
and mortality rate reductions.

Step 17. Report outcomes to
stakeholders

Next steps may include weekly or monthly sharing of primary
outcome audits as well as sharing secondary outcome metrics for
heart failure readmission and mortality rates monthly or quarterly
with key stakeholders and the organization at large.

Step 18. Identify next steps

Next steps may include reviewing what went well and identifying
continued areas of needed improvement and determining next
course of action for continued acceleration of core objectives.
Next steps may include sharing successes and failures with all key
stakeholders, tying back success to the core purpose of positively
improving healthcare outcomes of the heart failure patient
population.

Step 19. Disseminate findings
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Table 2
EBP Survey Subscales Pre and Post Part 1
Organizational
Unit Culture
Knowledge and
Culture
Skills of Nurses
N*
Pre
Post
Pre
Post
Pre
Post
M (SD)
M (SD)
M (SD)
M (SD) M (SD)
M (SD)
RN
46
31.7
33.9
19.8
20.4
27.4
28.3
(6.0)
(5.8)
(2.7)
(3.4)
(4.4)
(4.4)
LPN
6
37.7
35.2
21.7
21.3
30.0
30.0
(5.5)
(5.8)
(2.9)
(2.0)
(4.4)
(3.3)
Associates/
33
31.1
32.6
19.7
19.6
26.6
27.1
Diploma
(6.1)
(5.2)
(2.4)
(2.6)
(4.4)
(4.3)
Bachelors
8
33.7
36.8
20.7
23.5
30.3
31.6
(4.7)
(6.5)
(3.3)
(1.5)
(2.8)
(2.8)
Masters
4
33.3
38.0
18.0
20.3
28.0
32.0
(7.8)
(6.9)
(3.0)
(7.6)
(5.0)
(3.6)
All
53
32.1
34.1
19.9
20.5
27.6
28.5
Participants
(6.1)
(5.7)
(2.7)
(3.2)
(4.3)
(4.3)
*Note: post data, slight variance in pre and post noted likely due to change in education during
project time period.
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Table 3
EBP Survey Subscales Pre and Post Part 2
Time
Pre
M (SD)
6.6 (1.8)

Total Score
N*
Post
Post
Pre
Post
M (SD)
M (SD)
M (SD)
M (SD)
RN
46
7.2 (1.8)
8.1 (1.4) 93.5
97.9
(13.4)
(14.5)
LPN
6
8.0 (2.0) 7.3 (1.8) 8.3 (8.0) 8.3 (0.8) 105.7
102.2
(16.1)
(12.4)
Associates/ 33
6.8 (1.8) 7.0 (1.6) 7.9 (1.6) 7.9 (1.3) 92.1
94.2
Diploma
(14.0)
(13.3)
Bachelors
8
6.3 (1.9) 8.3 (1.7) 8.2 (1.4) 9.0 (0.9) 99.2
109.1
(8.5)
(10.9)
Masters
4
5.7 (1.5) 6.8 (3.0) 7.0 (1.0) 8.3 (2.1) 92.0
105.2
(15.1)
(21.4)
All
53
6.7 (1.8) 7.2 (1.7) 7.9 (1.5) 8.1 (1.3) 94.2
98.4
Participants
(13.5)
(14.1)
*Note: post data, slight variance in pre and post noted likely due to change in education during
project time period.

Attitude
Pre
M (SD)
7.9 (1.5)
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Table 4
EBP Survey Subscales Mann-Whitney U
Mann-Whitney U
Organizational Culture

.156

Unit Culture

.165

Knowledge and Skills
of Nurses
Time

.301

Attitude

.595

Total Score

.184

*Statistically significant at <0.05

.131
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Appendix A

(CDC, 2020)
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Appendix B
Table 1
Comparison of ACCF/AHA Stages of HF and NYHA Functional Classifications of HF
ACCF/AHA Stages of HF
Stage A.
High risk for HF but without structural heart disease
or symptoms of HF
Stage B.
Structural heart disease but without signs or
symptoms of HF
Stage C.
Structural heart disease with prior or current
symptoms of HF

NYHA Functional Classification
None

I.

I.

II.

III.

IV.

Stage D.
Refractory HF requiring specialized interventions

V.

No limitations of physical activity. Ordinary
physical activity does not cause symptoms of
HF.
No limitations of physical activity. Ordinary
physical activity does not cause symptoms of
HF.
Slight limitation of physical activity.
Comfortable at rest, but ordinary physical
activity results in symptoms of HF.
Marked limitation of physical activity.
Comfortable at rest, but less than ordinary
activity causes symptoms of HF.
Unable to carry on any physical activity
without symptoms of HF, or symptoms of
HF at rest.
Unable to carry on any physical activity
without symptoms of HF, or symptoms of
HF at rest.

Table 2
Stage A Recommendations
Recommendations
Hypertension and lipid disorders should be controlled in accordance with contemporary
guidelines to lower the risk of HF.
Other conditions that may lead to or contribute to HF, such as obesity, diabetes mellitus,
tobacco use, and known cardiotoxic agents, should be controlled or avoided.

COR LOE
I
A
I

C

COR
I

LOE
A

I

B

I
I

A
A

Table 3
Stage B Recommendations for Treatment of Stage B HF
Recommendations
In patients with a history of MI and reduced EF, ACE inhibitors or ARBs should be sued to
prevent HF.
In patients with MI and reduced EF, evidence-based beta blockers should be used to prevent
HF.
In patients with MI, statins should be used to prevent HF.
Blood pressure should be controlled to prevent symptomatic HF.
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ACE inhibitors should be used in all patients with a reduced EF to prevent HF.
Beta blockers should be used in all patients with a reduced EF to prevent HF.
An ICD is reasonable in patients with symptomatic ischemic cardiomyopathy who are > 40
days post-MI, have an LVEF < 30%, and are on GDMT.
Nondihydropyridine calcium channel blockers may be harmful to patients with low LVEF.

I
I
IIa

A
C
B

III:
C
Harm

Table 4
Stage C Recommendations-Nonpharmacological Interventions
Recommendations
Education-patients with HF should receive specific education to facilitate HF self-care. (pg. 9,
other risk interventions)
Sodium restriction-sodium restriction is reasonable for patients with symptomatic HF to reduce
congestive symptoms.
Activity, exercise prescription, and cardiac rehab-exercise training (or regular physical activity)
is recommended as safe and effective for patients with HF who are able to participate to
improve functional status. (pg. 9, other risk interventions)
Activity, exercise prescription, and cardiac rehab-cardiac rehabilitation can be useful in
clinically stable patients with HF to improve functional capacity, exercise duration, healthrelated quality of life (HRQOL), and mortality. (pg. 9, other risk interventions)

COR
I

LOE
B

IIa

C

I

A

IIa

B

COR
I

LOE
C

I

C

I

B

IIa

B

COR
I

LOE
C

I

C

Table 5
Assessment Recommendations
Recommendations
A thorough history and physical examination should be obtained/performed in patients
presenting with HF to identify cardiac and noncardiac disorders or behaviors that might cause
or accelerate the development or progression of HF.
In patients with idiopathic dilated cardiomyopathy (DCM), a 3-generational family history
should be obtained to aid in establishing diagnosis of familial DCM.
Volume status and vital signs should be assessed at each patient encounter. This includes serial
assessment of weigh, as well as estimates of jugular venous pressure and the presence of
peripheral edema or orthopnea. (pg. 3, weight, JVP, lower ext. edema)
Validated multivariable risk scores can be useful to estimate subsequent risk of mortality in
ambulatory or hospitalized patients with HF.

Table 6
Diagnostic Tests Recommendations
Recommendations
Initial laboratory evaluation of patients presenting with HF should include a complete blood cell
count, urinalysis, measurement of serum electrolytes (including calcium and magnesium), blood
urea nitrogen, serum creatinine, glucose, and thyroid-stimulating hormone, a fasting lipid
profile, and liver function tests.
Serial monitoring, when indicated, should include serum electrolyte levels and renal function.
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A 12-lead electrocardiogram (ECG) should be performed initially on all patients presenting
with HF.
Screening for hemochromatosis or HIV is reasonable in selected patients who present with HF.
Diagnostic tests for rheumatological diseases, amyloidosis, or pheochromocytoma are
reasonable in patients presenting with HF in whom there is a clinical suspicion of these
diseases.

I

C

IIa
IIa

C
C

COR
I

LOE
A

COR
I

LOE
A

I

A

IIa

BNR
BNR

Table 7
Biomarkers for Diagnosis, 2017
Recommendations
In patients presenting with dyspnea, measurement of natriuretic peptide biomarkers is useful to
support a diagnosis or exclusion of HF.

Table 8
Biomarkers for Prognosis or Added Stratification, 2017
Recommendations
Measurement of BNP or NT-proBNP is useful for establishing prognosis or disease severity in
chronic HF.
Measurement of baseline levels of natriuretic peptide biomarkers and/or cardiac troponin on
admission to the hospital is useful to establish a prognosis in acutely decompensated HF.
During a HF hospitalization, a predischarge natriuretic peptide level can be useful to establish a
postdischarge prognosis.
In patients with chronic HF, measurement of other clinically available tests, such as biomarkers
of myocardial injury or fibrosis, may be considered for additive risk stratification.

IIb

Table 9
Recommendations for Noninvasive Imaging
Recommendations
Patients with suspected, acute, or new-onset HF should undergo a CXR
A 2-dimensional echocardiogram with doppler should be obtained for initial evaluation of HF
Repeat measurement of EF is useful in patients with HF who have had a significant change in
clinical status or received treatment that might affect cardiac function, or for consideration of
device therapy
Noninvasive imaging to detect myocardial ischemia and viability is reasonable in HF and
CAD
Radionuclide ventriculography or MRI can be useful to assess LVEF and volume
MRI is reasonable when assessing myocardial infiltration or scar
Routine repeat measurement of LV function assessment should NOT be performed

COR
I
I
I

LOE
C
C
C

IIa

C

IIa
IIa
III:
No
Benefi
t

C
B
B
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Table 10
Recommendations for Invasive Evaluation
Recommendations
Monitoring with a pulmonary artery catheter should be performed in patients with respiratory
distress or impaired systemic perfusion when clinical assessment is inadequate
Invasive hemodynamic monitoring can be useful for carefully selected patients with acute HF
with persistent symptoms and/or when hemodynamics are uncertain
When ischemia may be contributing to HF, coronary arteriography is reasonable
Endomyocardial biopsy can be useful in patients with HF when a specific diagnosis is
suspected that would influence therapy
Routine use of invasive hemodynamic monitoring is NOT recommended in normotensive
patients with acute HF
Endomyocardial biopsy should NOT be performed in the routine evaluation of HF

COR
I

LOE
C

IIa

C

IIa
IIa

C
C

III: No
Benefit
III:
Harm

B
C

Table 11
Recommendations for Pharmacological Therapy for Management of Stage C HFrEF
Recommendations
Diuretics are recommended in patients with HFrEF with fluid retention. (pg. 3, meds prior to
admit)
ACE inhibitors are recommended for all patients with HFrEF. (pg. 3, meds prior to admit)
ARBs are recommended in patients with HFrEF who are ACE inhibitor-intolerant. (pg. 3, meds
prior to admit)
ARBs are reasonable as alternatives to ACE inhibitors as first-line therapy in HFrEF. (pg. 3,
meds prior to admit)
Addition of an ARB may be considered in persistently symptomatic patients with HFrEF on
GDMT. (pg. 3, meds prior to admit)
Routine combined use of an ACE inhibitor, ARB, and aldosterone antagonist is potentially
harmful.
Use of 1 of the 3 beta blockers proven to reduce mortality is recommended for all stable
patients. (pg. 3, meds prior to admit)
Aldosterone receptor antagonists are recommended in patients with NYHA class II-IV HF who
have LVEF <35%.(pg. 3, meds prior to admit)
Aldosterone receptor antagonists are recommended in patients following an acute MI who have
LVEF <40% with symptoms of HF or diabetes mellitus. (pg. 3, meds prior to admit)
Inappropriate use of aldosterone receptor antagonists may be harmful.
The combination of hydralazine and isosorbide dinitrate is recommended for African Americans
with NYHA class III-IV HFrEF on GDMT.
A combination of hydralazine and isosorbide dinitrate can be useful in patients with HFrEF who
cannot be given ACE inhibitors or ARBs.
Digoxin can be beneficial in patients with HFrEF.
Patients with chronic HF with permanent/persistent/paroxysmal AF and an additional risk factor
for cardioembolic stroke should receive chronic anticoagulant therapy.
The selection of an anticoagulant agent should be individualized.
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Chronic anticoagulation is reasonable for patients with chronic HF who have
permanent/persistent/paroxysmal AF but are without an additional risk factor for cardioembolic
stroke. (pg. 3, meds prior to admit)
Anticoagulation is NOT recommended in patients with chronic HFrEF without AF, a prior
thromboembolic event, or a cardioembolic source.

Statins are NOT beneficial as adjunctive therapy when prescribed solely for HF.

Omega-3 PUFA supplementation is reasonable to use as adjunctive therapy in HFrEF or HFpEF
patients.
Nutritional supplements as treatment for HF are NOT recommended in HFrEF.

Hormonal therapies other than to correct deficiencies are NOT recommended in HFrEF.

Drugs known to adversely affect the clinical status of patients with HFrEF are potentially
harmful and should be avoided or withdrawn.
Long-term use of an infusion of a positive inotropic drug is NOT recommended and may be
harmful except as palliation.
Calcium channel-blocking drugs are NOT recommended as routine treatment HFrEF.
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Table 12
Pharmacological Treatment for Stage C HF with Reduced Ejection Fraction: Recommendations,
2017
Recommendation
The clinical strategy of inhibition of the renin-angiotensin system with:
ACE Inhibitors, OR ARBs,
OR ARNI, In conjunction with evidence-based beta blockers, and aldosterone antagonist in
selected patients, is recommended for patients with chronic HFrEF to reduce morbidity and
mortality
The use of ACE inhibitors is beneficial for patients with prior or current symptoms of chronic
HFrEF to reduce morbidity and mortality.
The use of ARBs to reduce morbidity and mortality is recommended in patients with prior or
current symptoms of chronic HFrEF who are intolerant to ACE inhibitors because of cough or
angioedema.
In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACE
inhibitor or ARB, replacement by and ARNI is recommended to further reduce morbidity and
mortality.
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ARNI should not be administered concomitantly with ACE inhibitors or within 36 hrs of the last
dose of an ACE inhibitor.
ARNI should not be administered to patients with a history of angioedema.

III:
B-R
Harm
III:
C-EO
Harm

Table 13
Ivabradine: Recommendation , 2017
Recommendation
Ivabradine can be beneficial to reduce HF hospitalization for patients with symptomatic (NYHA
class II-III) stable chronic HFrEF (LVEF <35%) who are receiving GDMT, including a beta
blocker at maximum tolerated dose, and who are in sinus rhythm with a heart rate of >70 bpm at
rest.
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Table 14
Pharmacological Treatment for Stage C HFpEF: Recommendations, 2017
Recommendation
Systolic and diastolic blood pressure should be controlled in patients with HFpEF in
accordance with published clinical practice guidelines to prevent morbidity.
Diuretics should be used for relief of symptoms due to volume overload in patients with
HFpEF.
Coronary revascularization is reasonable in patients with CAD in who symptoms (angina) or
demonstrable myocardial ischemia is judged to be having and adverse EFFECT on
symptomatic HFpEF despite GDMT.
Management of AF according to published clinical practice guidelines in patients with HFpEF
is reasonable to improve symptomatic HF.
The use of beta-blocking agents, ACE inhibitors, and ARBs in patients with hypertension is
reasonable to control blood pressure in patients with HFpEF.
In appropriately selected patients with HFpEF (with EF >45%, elevated BNP levels of HF
admission within 1 year, estimated glomerular filtration rate >30 mL/min, creatinine
<2.5mg/dL, potassium <5.0 mEq/L), aldosterone receptor antagonists might be considered to
decrease hospitalizations.
The use of ARBs might be considered to decrease hospitalization for patients with HFpEF.
Routine use of nitrates or phosphodlesterase-5 inhibitors to increase activity or QoL in patients
with HFpEF is ineffective.
Routine use of nutritional supplements is not recommended for patients with HFpEF.
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Table 15
Recommendations for Device Therapy for Management of Stage C HF
Recommendation
ICD therapy is recommended for primary prevention of SCD in selected patients with HFrEF
>40 days post-MI with LVEF <35% and NYHA class II or III symptoms on chronic GDMT,
who are expected to live >1 year
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CRT is indicated for patients who have LVEF <35%, sinus rhythm, LBBB with a QRS duration
of >150ms, and NYHA class II, III, or ambulatory class IV symptoms on GDMT.

ICD therapy is recommended for primary prevention of SCD in selected patients with HFrEF >
40 days post-MI with LVEF <30% and NYHA class I symptoms while receiving GDMT, who
are expected to live >1 year
CRT can be useful for patients who have LVEF <35%, sinus rhythm, a non-LBBB pattern with
QRS >150ms, and NYHA class III/ambulatory class IV symptoms on GDMT
CRT can be useful for patients who have LVEF <35%, sinus rhythm, LBBB with a QRS
duration of 120-149 ms, and BYHA class II, III, or ambulatory class IV symptoms on GDMT
CRT can be useful for patients with AF and LVEF <35% on GDMT if a) the patient requires
ventricular pacing or otherwise meets CRT criteria and b) atrioventricular nodal ablation or rate
control allows near 100% ventricular pacing with CRT
CRT can be useful for patients on GDMT who have LVEF <35% and are undergoing new or
replacement device implantation with anticipated ventricular pacing (>40%)
An ICD is of uncertain benefit to prolong meaningful survival in patients with a high risk of
non-sudden death such as frequent hospitalizations, frailty, or severe comorbidities
CRT may be considered for patients who have LVEF <35%, sinus rhythm a non-LBBB pattern
with QRS 120-149 ms, and NYHA class III/ambulatory class IV symptoms on GDMT
CRT may be considered for patients who have LVEF <35%, sinus rhythm, a non-LBBB pattern
with QRS >150 ms, and NYHA class II symptoms on GDMT
CRT may be considered for patients who have LVEF <30%, ischemic etiology of HF, sinus
rhythm, LBBB with QRS >150 ms, and NYHA class I symptoms on GDMT
CRT is not recommended for patients with NYHA class I or II symptoms and non-LBBB
pattern with QRS <150 ms

CRT is not recommended for patients whose comorbidities and/or frailty limit survival to <1
year
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Table 16
Recommendations for Therapies in the Hospitalized HF Patient
Recommendation
HF patients with fluid overload should be treated with IV diuretics
HF patients receiving loop diuretic therapy should receive an initial parenteral dose greater than
or equal to their chronic oral daily dose; then does should be serially adjusted (pg. 4, parental
therapies)
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HFrEF patients requiring HF hospitalization on GDMT should continue GDMT except in cases
of hemodynamic instability or where indicated (pg. 4, oral meds during hospitalization)
Initiation of beta-blocker therapy at a low dose is recommended after optimization of volume
status and discontinuation of IV agents
Thrombosis/thromboembolism prophylaxis is recommended for patient hospitalized with
HF(pg, 4 bottom and 5 top, DVT prophylaxis)
Serum electrolytes, urea nitrogen, and creatine should be measured during the titration of HF
medications including diuretics
When diuresis is inadequate, it is reasonable to
a. give higher doses of IV loop diuretics or
b. add a second diuretic (e.g., thiazide)
Low-dose dopamine infusion may be considered with loop diuretics to improve diuresis
Ultrafiltration may be considered for patients with obvious volume overload
Ultrafiltration may be considered for patients with refractory congestion
IV nitroglycerin, nitroprusside, or nesiritide may be considered an adjuvant to diuretic therapy
for stable patients with HF
In patients hospitalized with volume overload and severe hyponatremia, vasopressin antagonist
may be considered
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Table 17
Recommendations for Hospital Discharge and Strategies to Reduce Readmissions
Recommendation
Performance improvement systems in the hospital and early postdischarge outpatient setting to
identify HF for GDMT
Before hospital discharge, at the first postdischarge visit, and in subsequent follow-up visits, the
following should be addressed:
a. Initiation of GDMT if not done or contraindicated (pg. 5 bottom, top 6-discharge
medications)
b. Causes of HF, barriers to care, and limitations in support
c. Assessment of volume status and blood pressure with adjustment of HF therapy (pg. 5,
exam JVP, rales, lower ext. edema, BP)
d. Optimization of chronic oral HF therapy (pg. 6, dc medications-need to review if
documented contraindication)
e. Renal function and electrolytes (pg. 5 dc info, labs closest to dc)
f. Management of comorbid conditions (pg. 9-if applicable asks about diabetes
management)
g. HF education, self-care, emergency plans, and adherence
h. Palliative or hospice care
Multidisciplinary HF disease-management programs for patients at high risk for hospital
readmission are recommended
A follow-up visit within 7-14 days and/or telephone follow-up within 3 days of hospital
discharge is reasonable (pg. 8, follow up visit scheduled) (pg. 9 post d/c transition)
Use of clinical risk-prediction tools and/or biomarkers to identify higher-risk patients is
reasonable

Table 18
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Recommendation for Hypertension in Stage C HFrEF, 2017
Recommendation
Patients with HFrEF and hypertension should be prescribed GDMT titrated to attain systolic BP
<130 mm hg
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Table 19
Treating Hypertension in Stage C HFpEF: Recommendation, 2017
Recommendation
Patients with HFpEF and persistent hypertension after management of volume overload should
be prescribed GDMT titrated to attain systolic blood pressure <130 mm hg

Table 20
Outcome Measures for HF
Measure
Congestive HF mortality rate (*NQF endorsed)
HF 30-d mortality rate (NQF endorsed)
Congestive HF admission rate (NQF endorsed)
HF 30-d risk-standardized HF readmission rate (NQF
endorsed)

Developer
Agency for Health Research and Quality
(AHRQ)
Centers for Medicare and Medicaid Services
Agency for Health Research and Quality
Centers for Medicare and Medicaid Services

*NQF-National Quality Forum

Table 21
ACCF/AHA/AMA-PCPI 2011 HF Measurement Set, Inpatient
Measure

Description

Care Setting

LVEF
assessment

Percentage of patients >18 with a principal dc dx of HF
with documentation in the hospital record of the results
of an LVEF assessment performed either before arrival
or during hospitalization, OR documentation in the
hospital record that LVEF assessment is planned for after
discharge
Percentage of patients aged >18 with a dx of HF with a
current or prior LVEF <40% who were prescribed betablocker therapy with bisoprolol, carvedilol, or sustainedrelease metoprolol succinate either within a 12-mo period
when seen in the outpatient setting or at hospital
discharge
Percentage of patients aged >18 with a dx of HF with a
current of prior LVEF <40% who were prescribed ACE
inhibitor or ARB therapy either within a 12-mo period

Inpatient

Beta-blocker
therapy for
LVSD

ACE inhibitor
or ARB therapy
for LVSD

Inpatient and
outpatient

Level of
Measurement
▪ Individual
practitioner
▪ Facility

▪
▪

Inpatient and
outpatient

▪
▪

Individual
practitioner
Facility

Individual
practitioner
Facility
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Postdischarge
appointment for
HF patients

when seen in the outpatient setting or at hospital
discharge
Percentage of patients, regardless of age, discharged from
an inpatient facility to ambulatory care or home health
care with a principal dc dx of HF for whom a follow-up
appt. was scheduled and documented including location,
date and time for a follow-up office visit, or home health
visit (as specified)

▪

Inpatient

Table 22
Water Restriction
Recommendation
Fluid restriction (1.5L-2L/day) is reasonable in stage D, especially in
patients with hyponatremia, to reduce congestive symptoms
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Table 23
Coordinating Care for Patients with Chronic HF
Recommendation
Effective systems of care coordination with special attention to care
transitions should be deployed for every patient with chronic HF that
facilitate and ensure effective care that is designed to achieve GDMT and
prevent hospitalization. (pg. 9 post d/c transition)
Every patient with HF should have a clear, detailed, and evidence-based
plan of care that ensures the achievement of GDMT goals, effective
management of comorbid conditions, timely follow-up with the healthcare
team, appropriate dietary and physical activities, and compliance with
secondary prevention guidelines for cardiovascular disease. This plan of
care should be updated regularly and made readily available to all members
of each patient’s healthcare team. (pg. 9 post d/c transition)
Palliative and support care is effective for patients with symptomatic
advanced HF to improve quality of life.

(ACCF & AHA, 2017)

Facility
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Appendix C
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Appendix D
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Appendix E
Evidence Based Educational and Follow-up Program to Improve Heart Failure Self-Care
Objectives
•

Describe evidence-based practice (EBP)

•

Discuss key components of an EBP environment

•

Review the Johns Hopkins Evidence-Based Practice Model (JHNEBP)

What is EBP?
A. Three core components
1. Best research evidence
2. Clinical expertise
3. Patient values and preferences
Why is EBP important?
A. Medical knowledge and accepted practice change rapidly
B. Example, COVID-19 research and EBP application
Creating a supportive EBP environment
A. Steps for success
1. Adoption of an EBP model
2. Organization culture
3. Embed into nursing philosophy
4. Developing a strategic plan
5. Committed organizational leadership
6. Identifying and developing mentors
7. Overcoming barriers
8. Leading change
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9. Developing EBP skills and knowledge
10. Interprofessional collaboration
11. Setting expectations for EBP
12. Developing and EBP committee
Meet nurse Sally
A. Case example
1. Problem identification
2. Review of literature
3. Review for evidence for quality, reliability
4. Organizational application
Nursing EBP model
A. Purpose of nursing EBP model
B. JHNEBP: practice question, evidence, and translation (PET)
C. PET steps
Meet nurse Bob
A. Case example
1. Problem identification
2. Present to EBP committee for consideration for hospital project
3. Utilization of JHNEBP steps to apply EBP
References and Post Test

INTRO OF AN EBP MODEL TO IMPROVE HEART FAILURE 52
Appendix F
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Appendix G

Introduction of a Nursing Evidenced-Based Practice Model to Improve Heart Failure Care at a
Rural Community Hospital
Date:
Dear TRMC Nurse,
You are being invited to complete the attached questionnaire about evidence-based practice. There are no
reasonably foreseeable risks associated with your participation in this evidence-based practice project.
The data you provide will be used to review current state of nursing evidence-based practice and post
review of evidence-based practice after education. The questionnaire will take approximately 10 minutes
to complete. You will need to create a unique, memorable 4-digit ID number in the survey, you will need
to remember this number for the post-education survey. Your completed questionnaire will be securely
stored at Three Rivers Medical Center. Individuals from the department of nursing at Bellarmine
University and the Bellarmine University Institutional Review Board may inspect these records. In all
other respects, however, the data will be held in confidence to the extent permitted by law. Should the
data be published, your identity will not be disclosed.
Please remember that your participation in this study is voluntary. By completing and returning or
submitting the attached questionnaire, you are voluntarily agreeing to participate. You are free to decline
to answer any particular question that may make you feel uncomfortable or which may render you
prosecutable under law.
You acknowledge that all your present questions have been answered in language you can understand. If
you have any questions about this project, please contact Dr. Julianne Evers at jevers01@bellarmine.edu
or Brandi Fields at 606-831-5521. If you have any questions about your rights as a project participant,
you may call the Institutional Review Board (IRB) office at 502-272-8032. You will be given the
opportunity to discuss any questions about your rights as a participant, in confidence, with a member of
the committee. This is an independent committee composed of members of the University community
and lay members of the community not connected with this institution. The IRB has reviewed this
project.
Sincerely,

Julianne Evers, DNP, APRN, AGACNP-BC, CCRN
Nursing Assistant Professor-Bellarmine University

Brandi Fields, MSN, RN, NEA-BC
DNP Student-Bellarmine University
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Appendix H
Table 1
Project Costs
EBP Committee Members**
CNO
RN
RN
Licensed Professional
Licensed Professional

Annual Cost-Time*
$1,848
$648
$648
$360
$360

Year 2 Cost-Time
$1,848
$648
$648
$360
$360

Physician

$2400

$2400

Advanced Practice Clinician
RN Educator

$1200
$648

$1200
$648
GRAND TOTAL=$16,224
*estimated two hours per committee member per month, average rates for position and area
**committee meetings during normal business hours, additional pay may not be required for
majority of members depending on position
Table 2
HRRP (Hospital Readmission Reduction Program)
Description
HRRP Estimate

Year 1 Penalty
$153,286

Year 2 Penalty
$153,286
GRAND TOTAL=$306,572

*estimated penalty
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Appendix I
JHNEBP Project Management Guide
Initial EBP Question:
EBP Team Leader:
EBP Team Members:
Activities
Practice Question
Step 1: Recruit interprofessional team
Step 2: Define the problem
Step 3: Develop and refine the EBP
question
Step 4: Identify stakeholders
Step 5: Determine responsibility for
project leadership
Step 6: Schedule team meetings
Evidence
Step 7: Conduct internal and external
search for evidence
Step 8: Appraise the level and quality
of each piece of evidence
Step 9: Summarize the individual
evidence

Start
Date

Days
Required

End
Date

Person Assigned

Milestone

Comment/Resources
Required
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Step 10: Synthesize overall strength
and quality of evidence
Step 11: Develop recommendations
for change based on evidence
synthesis
• Strong, compelling evidence,
consistent results
• Good evidence, consistent
results
• Good evidence, conflicting
results
• Insufficient or absent
evidence
Translation
Step 12: Determine fit, feasibility,
and appropriateness of
recommendation(s) for translation
path
Step 13: Create action plan
Step 14: Secure support and
resources to implement action plan
Step 15: Implement action plan
Step 16: Evaluate outcomes
Step 17: Report outcomes to
stakeholders
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Step 18: Identify next steps
Step 19: Disseminate findings
(Dang, Dearholt, 2017)

